This news section highlights the disparity between multicancer detection test promises and actual evidence of benefits.
This news section is written by a medical journalist and offers Cancer Cytopathology readers timely information on events, issues, and personalities of interest to the subspecialty. In this first of a two‐part series on new blood‐based cancer tests, direct‐to‐consumer pitches for multicancer detection have far outpaced evidence of real‐world benefits.
No takes yet. Share an insight, caveat, or question.
Nelson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: